Skip to content
healthcare.dev

Pryidostigmine Bromide

NDC 16571-833, Pyridostigmine Bromide, solution, from Rising Pharma Holdings, Inc..

Product NDC
16571-833
Status
Listed
Labeler
Rising Pharma Holdings, Inc.
Dosage form
SOLUTION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA208797
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/16571-833 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PYRIDOSTIGMINE BROMIDE60 mg/5mL

Pharmacologic classes

Cholinesterase Inhibitor [EPC]; Cholinesterase Inhibitors [MoA]

Package NDCNDC-11Package
16571-833-1616571083316473 mL in 1 BOTTLE, PLASTIC (16571-833-16)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/beda905e-005a-439d-ac74-92db4e269780
  • NADAC price for package 16571083316

    GET /v1/drugs/nadac/16571083316

Use it

Look up 16571-833 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/16571-833 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 16571-833. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.